Ginkgo Bioworks
9.57
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Ginkgo Bioworks
Ginkgo Bioworks, Inc. está construyendo una plataforma para permitir a los clientes programar células tan fácilmente como programamos computadoras. La plataforma de Ginkgo es independiente del mercado y permite aplicaciones de biotecnología en diversos mercados, desde alimentos y agricultura hasta productos químicos industriales y productos farmacéuticos. Ginkgo también apoya activamente una serie de esfuerzos de bioseguridad para responder al COVID-19, incluida la optimización de la fabricación de vacunas, el descubrimiento de terapias y las pruebas conjuntas K-12.
Trade GPT
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.